What You Should Know
WellStack announced the acquisition of DeLorean AI, a healthcare artificial intelligence company specializing in predictive analytics, clinical risk stratification, and prescriptive decision support.The transaction unifies WellStack’s agentic healthcare data management platform and modular Decision Hubs with DeLorean AI’s predictive intelligence and next-action recommendation engine.The combined entity bridges the gap across the healthcare analytics maturity curve:
Read More
Radiology Partners to Acquire Everlight Radiology, Creating a Global Leader in Teleradiology
What You Should Know
Radiology Partners, Inc. (RP) has signed a definitive agreement to acquire Everlight Radiology, a major international teleradiology provider serving hospitals and imaging centers across the United Kingdom, Ireland, Australia, New Zealand, and South Africa.The transaction unifies Everlight’s global network with RP Clinical Services’ vRad (Virtual Radiologic) division—the largest teleradiology practice in the United States—forming an international clinical teleradiology
Read More
FGV Capital Closes $35M Fund II and Rebrands to Scale Platform-First Venture Model
What You Should Know
FGV Capital (the venture arm of FGV, formerly known as Fiat Ventures) announced the final close of its $35M Fund II (inclusive of co-investment vehicles), oversubscribed from its initial $25M target.Fund II brings the firm’s total assets under management (AUM) to more than $60 million across its early-stage investment platform.Co-founded and led by Marcos Fernandez, Drew Glover, Alex Harris, and Rohit Ramkumar, the firm focuses on early-stage seed and pre-seed rounds at
Read More
Suki Launches Standalone AI Dictation Integrated Natively into Epic and MEDITECH Workflows
What You Should Know
Ambient Clinical Intelligence (ACI) leader Suki announced the launch of Suki Dictation, an AI-powered clinical dictation solution built natively inside Epic and MEDITECH electronic health records (EHRs).The solution can be deployed as an independent standalone replacement for legacy dictation tools or used alongside Suki’s ambient listening documentation on a single unified platform.Breaks the traditional vendor packaging model where health systems are forced into costly,
Read More
FDA Grants De Novo Authorization to Avulux, Establishing First Device Classification for Migraine Light Sensitivity
What You Should Know
The U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization to Avulux, establishing a first-of-its-kind, FDA-recognized medical device classification for precision optical filters designed to manage migraine-associated light sensitivity.Decreases the impact of light sensitivity in patients diagnosed with episodic migraine aged 12 years and older, serving as an over-the-counter, non-invasive complement to usual care and pharmacological
Read More
Roche Receives FDA Clearance for Elecsys pTau217, First Single-Biomarker Alzheimer’s Blood Test for Primary and Specialty Care
What You Should Know
The U.S. Food and Drug Administration (FDA) has cleared Roche’s Elecsys® Phospho-Tau (217P) Plasma (pTau217) blood test, developed in strategic collaboration with Eli Lilly and Company.It is the first and only FDA-cleared, single-biomarker blood test supporting both rule-in and rule-out assessment of amyloid pathology associated with Alzheimer’s disease using the exact same validated clinical cutoffs across both primary care and specialty neurology settings.The test is
Read More
Arintra Secures $25M to Scale GenAI Autonomous Medical Coding
What You Should Know
Arintra, an autonomous medical coding startup headquartered in Austin, Texas, with engineering operations in Bengaluru, raised approximately $25 million in a Series B funding round led by Define Ventures.The syndicate includes new strategic backing from Yale New Haven Ventures and Endeavor Ventures, alongside participation from existing investors Y Combinator, Ten13 Capital, Counterpart Ventures, Spider Capital, and Peak XV Partners (which previously led Arintra’s $21
Read More
UNC Health Rebrands Rex Health Ventures to Launch UNC Health Ventures Strategic Investment Platform
What You Should Know
UNC Health officially announced the rebranding and expansion of Rex Health Ventures into UNC Health Ventures, establishing a unified, systemwide corporate venture capital (CVC) and strategic investment platform.The venture platform builds on more than a decade of strategic healthcare investing, having supported nearly 30 early-stage healthcare companies since its founding in 2012.UNC Health Ventures is directly funded through UNC Health’s broader investment portfolio,
Read More
Cityblock Acquires Homeward and Secures $116M to Unify Urban-Rural Care
What You Should Know
Cityblock Health entered into a definitive agreement to acquire Homeward Health in an all-stock transaction, paired with a $116M Series E financing round led by General Catalyst.The combined entity now serves nearly 200,000 members nationwide across Medicaid, Medicare Advantage, and dual-eligible programs, generating $2.2B in annualized revenue (up 77% year-over-year and more than 4x its 2021 fundraise level).Homeward Health brings a dedicated rural-first Medicare
Read More
Bristol Myers Squibb Partners with Chai Discovery for AI Antibody Design
What You Should Know
Chai Discovery announced a strategic biopharmaceutical collaboration with Bristol Myers Squibb (BMS) to advance the discovery and engineering of therapeutic antibodies using artificial intelligence.Bristol Myers Squibb will integrate Chai’s proprietary molecular folding and de novo design models across its drug discovery portfolio to power an AI-driven, continuously learning discovery system.Chai Discovery’s platform acts as a computer-aided design (CAD) suite for
Read More
